Aprecia Pharmaceuticals

About:

Aprecia Pharmaceuticals develops precision drug delivery systems and products.

Website: http://www.aprecia.com

Top Investors: Hercules Capital, Deerfield, Alpha Capital, Harbor View Advisors

Description:

Aprecia Pharmaceuticals Company develops and manufactures precision drug delivery systems and products. Its products include CustomRelease that provides various time release profiles; ZipDose, a orally dispersing wafers pairing a high dose ceiling with times, taste-masking options, and IR/ER combinations; and NanoDose that is suited for products requiring submilligram doses. The company also offers ImplantaDose, which is suited for post surgical management of infections and associated pain, and sequential release of biomimetic proteins and peptides. Aprecia Pharmaceuticals Company was incorproated in 2003 and is based in Langhorne, Pennsylvania.

Total Funding Amount:

$158M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Langhorne, Pennsylvania, United States

Founded Date:

2003-01-01

Contact Email:

bizdev(AT)aprecia.com

Founders:

Number of Employees:

51-100

Last Funding Date:

2016-07-05

IPO Status:

Private

Industries:

© 2025 bioDAO.ai